Bayesian Capital Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,600
Closed -$100K 223
2025
Q3
$100K Buy
+10,600
New +$89.2K 0.02% 484
2024
Q1
Sell
-23,400
Closed -$362K 839
2023
Q4
$362K Buy
23,400
+3,400
+17% +$44.4K 0.04% 455
2023
Q3
$274K Buy
+20,000
New +$294K 0.03% 490
2023
Q2
Sell
-10,800
Closed -$259K 837
2023
Q1
$259K Buy
+10,800
New +$235K 0.03% 549

Other funds holding CYRX

Bayesian Capital Management's CYRX Position: Q4 2025 in Review

Bayesian Capital Management sold out of CryoPort (CYRX) in Q4 2025, closing a stake of 10,600 shares — an estimated $100K sold.

Bayesian Capital Management first reported a position in CYRX in Q1 2023 and held it in 4 quarters. The position peaked at $362K in Q4 2023. 172 funds tracked by Wall St. Rank hold CYRX as of Q4 2025.

  • Bayesian Capital Management reported no remaining CryoPort position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 10,600 CryoPort shares in Q4 2025, an estimated $100K.
  • Bayesian Capital Management first reported a position in CryoPort in Q1 2023 and held it in 4 quarters.
  • Bayesian Capital Management's CryoPort position peaked at $362K in Q4 2023.
  • 172 funds tracked by Wall St. Rank held CryoPort as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.